BCRX · Biocryst Pharmaceuticals Inc · Fails to Deliver
$7.69
+0.06 (+0.79%)
At close · Nov 6
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$1.98B
Shares
257.30M
Volume · Nov 6
5.21M
Avg daily vol (3M)
4.93M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-09-21 | 328 | $8.68 | $2,847 |
| 2026-09-15 | 50,200 | $8.23 | $413,146 |
| 2026-09-10 | 1,475 | $8.81 | $12,995 |
| 2026-09-02 | 6,264 | $9.92 | $62,139 |
| 2026-08-31 | 10,200 | $9.82 | $100,164 |
| 2026-08-24 | 1,309 | $9.55 | $12,501 |
| 2026-08-07 | 966 | $9.30 | $8,984 |
Showing 1–7 of 7 settlements
Key facts
CIK
882796
CUSIP
09058V103
13F (30d)
129 filings
116 filers
Visit website
Investor relations